301 related articles for article (PubMed ID: 25586701)
1. Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample.
Moore F; Vickrey B; Fortin K; Lee L
Can J Neurol Sci; 2015 Jan; 42(1):55-63. PubMed ID: 25586701
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
Pakdaman H; Amini Harandi A; Gharagozli K; Abbasi M; Tabassi A; Ashrafi F; Ghaffarpor M; Sharifi S; Delavar Kasmae H; Assarzadegan F; Arabahmadi M; Behnam B
Int J Neurosci; 2017 Jun; 127(6):501-507. PubMed ID: 27279451
[TBL] [Abstract][Full Text] [Related]
3. Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires.
Fernández O; Baumstarck-Barrau K; Simeoni MC; Auquier P;
Mult Scler; 2011 Oct; 17(10):1238-49. PubMed ID: 21669936
[TBL] [Abstract][Full Text] [Related]
4. [French validation of the Multiple Sclerosis International Quality of Life Questionnaire].
Baumstarck-Barrau K; Pelletier J; Simeoni MC; Auquier P;
Rev Neurol (Paris); 2011; 167(6-7):511-21. PubMed ID: 21420136
[TBL] [Abstract][Full Text] [Related]
5. Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.
Ozakbas S; Akdede BB; Kösehasanogullari G; Aksan O; Idiman E
J Neurol Sci; 2007 May; 256(1-2):30-4. PubMed ID: 17379247
[TBL] [Abstract][Full Text] [Related]
6. Validation of Italian multiple sclerosis quality of life 54 questionnaire.
Solari A; Filippini G; Mendozzi L; Ghezzi A; Cifani S; Barbieri E; Baldini S; Salmaggi A; Mantia LL; Farinotti M; Caputo D; Mosconi P
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):158-62. PubMed ID: 10406981
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of selected outcome measures of participation restriction and quality of life in patients with multiple sclerosis.
Taheri M; Negahban H; Mostafaee N; Salehi R; Tabesh H
Disabil Rehabil; 2016; 38(5):482-6. PubMed ID: 25955822
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal study.
Patti F; Pappalardo A; Montanari E; Pesci I; Barletta V; Pozzilli C
J Neurol Sci; 2014 Feb; 337(1-2):180-5. PubMed ID: 24433926
[TBL] [Abstract][Full Text] [Related]
9. Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis.
Newsome SD; Guo S; Altincatal A; Proskorovsky I; Kinter E; Phillips G; You X; Sabatella G
Mult Scler Relat Disord; 2015 Jul; 4(4):350-7. PubMed ID: 26195056
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in multiple sclerosis: translation in French Canadian of the MSQoL-54.
Acquadro C; Lafortune L; Mear I
Health Qual Life Outcomes; 2003 Nov; 1():70. PubMed ID: 14636427
[TBL] [Abstract][Full Text] [Related]
11. Validation analysis of the Polish version of the Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL).
Jamroz-Wiśniewska A; Stelmasiak Z; Bartosik-Psujek H
Neurol Neurochir Pol; 2011; 45(3):235-44. PubMed ID: 21866480
[TBL] [Abstract][Full Text] [Related]
12. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
Ozakbas S; Cagiran I; Ormeci B; Idiman E
J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
[TBL] [Abstract][Full Text] [Related]
13. Asian adaptation and validation of an English version of the multiple sclerosis international quality of life questionnaire (MusiQoL).
Thumboo J; Seah A; Tan CT; Singhal BS; Ong B
Ann Acad Med Singap; 2011 Feb; 40(2):67-73. PubMed ID: 21468459
[TBL] [Abstract][Full Text] [Related]
14. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.
Idiman E; Uzunel F; Ozakbas S; Yozbatiran N; Oguz M; Callioglu B; Gokce N; Bahar Z
J Neurol Sci; 2006 Jan; 240(1-2):77-80. PubMed ID: 16277993
[TBL] [Abstract][Full Text] [Related]
15. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Centonze D; Gasperini C;
Mult Scler; 2011 Aug; 17(8):991-1001. PubMed ID: 21502310
[TBL] [Abstract][Full Text] [Related]
16. Validation of the multiple sclerosis international quality of life (MusiQoL) questionnaire in Norwegian patients.
Beiske AG; Baumstarck K; Nilsen RM; Simeoni MC
Acta Neurol Scand; 2012 Mar; 125(3):171-9. PubMed ID: 21470195
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
Kisic Tepavcevic D; Pekmezovic T; Stojsavljevic N; Kostic J; Dujmovic Basuroski I; Mesaros S; Drulovic J
Acta Neurol Belg; 2013 Dec; 113(4):403-9. PubMed ID: 23460394
[TBL] [Abstract][Full Text] [Related]
18. Improvement of quality of life and its relationship with neuropsychiatric outcomes in patients with multiple sclerosis starting treatment with natalizumab: A 3-year follow-up multicentric study.
Planche V; Moisset X; Morello R; Dumont E; Gibelin M; Charré-Morin J; Saubusse A; Mondou A; Reuter F; Defer G; Pelletier J; Brochet B; Clavelou P
J Neurol Sci; 2017 Nov; 382():148-154. PubMed ID: 29111011
[TBL] [Abstract][Full Text] [Related]
19. Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial.
Robinson D; Zhao N; Gathany T; Kim LL; Cella D; Revicki D
Curr Med Res Opin; 2009 May; 25(5):1121-30. PubMed ID: 19317608
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study.
Baumstarck K; Butzkueven H; Fernández O; Flachenecker P; Stecchi S; Idiman E; Pelletier J; Boucekine M; Auquier P
Health Qual Life Outcomes; 2013 Jul; 11():127. PubMed ID: 23895207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
